FDA Adverse Event Other Summary report: N

SURGIMEND

MDR report key: 2920197 · Received January 15, 2013

Report

Report Number
3004170064-2012-00068
Event Type
Other
Date Received
January 15, 2013
Date of Event
November 13, 2012
Report Date
December 19, 2012
Manufacturer
TEI BIOSCIENCES INC.
Product Code
FTM
PMA / PMN Number
071807
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

TWO (2) DEVICES WERE USED: DEVICE # 2: SURGIMEND, P/N 606-004-102, LOT #1101004 MANUFACTURED ON 01/21/2011 WITH AN EXPIRATION DATE OF 07-2013. HISTOLOGY OF DEVICE # 2 SHOWED A NORMAL DERMAL COLLAGEN STRUCTURE, AND A LOW DENSITY OF CELLS THROUGHOUT THE STRUCTURE. THERE WAS NO EVIDENCE OF A FOREIGN BODY REACTION.

Description of Event or Problem · 1

THE PATIENT WAS SCHEDULED FOR BREAST RECONSTRUCTION SURGERY. THE TWO DEVICES WERE IMPLANTED ON (B)(6) 2012; ONE UNDER THE UPPER SKIN FLAP (P/N 606-300-006, LOT # 1204052) AND THE OTHER AS A SLING (P/N 606-004-102, LOT # 1101004) UNDER AN EXPANDER WHICH WAS ALSO IMPLANTED. THE SURGERY WENT WELL AND THE PATIENT WAS RECOVERING AS EXPECTED OVER THE NEXT 2-3 WEEKS. IN (B)(6) SHE STARTED TO FEEL "ILL", HOWEVER, WITH NO SIGNS OF INFECTION. HER WHITE BLOOD CELL COUNT WAS NORMAL AND THERE WAS NO FEVER. ON (B)(6) 2012, IT WAS OBSERVED THAT THE CENTER OF THE UPPER DEVICE (P/N 606-300-006) FELT SOFT. PUS WAS ASPIRATED. DURING SURGERY, THE UPPER DEVICE APPEARED TO BE DISSOLVING AND WAS SUBSEQUENTLY EXPLANTED. PART OF THE SECOND DEVICE (P/N 06-004-102) WAS EXCISED AND EXPLANTED. THE REMAINDER WAS LEFT IN THE PATIENT. THE EXPANDER WAS ALSO EXPLANTED. AT THIS TIME THE PATIENT IS DOING AS EXPECTED. THE DOCTOR SUSPECTS EITHER AN INFECTION, HYPER-SENSITIVITY OR AUTO-IMMUNE REACTION LIKE THE PREVIOUSLY DIAGNOSED ERYTHEMA NODOSUM OR TO THE ANTIBIOTICS ADMINISTERED PRIOR TO OR DURING HER SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
22783 SURGIMEND SURGICAL MESH FTM TEI BIOSCIENCES INC. 606-300-006 1204052

Patients

Seq Age Sex Outcome Treatment
1 UNK Other| R